EVOTEC INDIGO

Welcome to the Brand page for “EVOTEC INDIGO”, which is offered here for Pharmaceutical cost management services;consultation in the field of regulatory compliance with respect to the pharmaceutical and medical products of others; regulatory compliance consulting services as they apply to clinical trials and preclinical drug development;medical and scientific research in the fields of neuroscience, oncology, immunology and inflammation, metabolic diseases and complications, respiratory and anti-infective diseases, dermatology, haematology, ophthalmology, rare diseases; conducting clinical trials for others in the field of neuroscience, oncology, immunology and inflammation, metabolic diseases and complications, respiratory and anti-infective diseases, dermatology, haematology, ophthalmology, rare diseases,; clinical research in the field of neuroscience, oncology, immunology and inflammation, metabolic diseases and complications, respiratory and anti-infective diseases but also in many other indications in the fields of dermatology, haematology, ophthalmology, rare diseases; pharmaceutical research services; medical and scientific research consultation pertaining to pharmacology, toxicology, drug metabolism, pharmacokinetics, bioanalysis, and tablet compression; research of medicines; development of pharmaceutical preparations, formulations, drug substances, drug products, active pharmaceutical ingredients, and medicines; research to develop pharmaceutical products; design and testing of new pharmaceutical products for others;.

Its status is currently believed to be active. Its class is unavailable. “EVOTEC INDIGO” is believed to be currently owned by “Evotec International GmbH”.